What's breaking now, across thousands of outlets.
Abcuro has collected $66 million a few months after saying its sole drug missed the mark in a muscle-weakening condition but had found hope in a subset of patients with less severe forms. CEO Alex ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The International Council of Nurses says some nurses and other health workers have gone unpaid for two to three months while facing serious risks to their lives.
The International Council of Nurses says some nurses and other health workers have gone unpaid for two to three months while facing serious risks to their lives.
The Council supported patients' 'personal freedom' to access a lethal substance at their request, if approved by a doctor.
UK fibrosis biotech Redx Pharma is making another go at a reverse merger, after its last attempt was axed in 2023. The ROCK inhibitor developer will take the Nasdaq listing of Skye ...
After a negative FDA advisory committee vote, Capricor Therapeutics said it will file additional data and analyses on its Duchenne muscular dystrophy therapy in hopes of a better shot at potential…
AS far as low-cost medical screening programmes go, the Transport Ministry’s pilot subsidised project for commercial vehicle drivers should be welcomed by most health-conscious Malaysians.
